Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5315)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,436
Price
$575.75
Total Value
$1.40M
Shares Held After
25,120
% of Holdings
8.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
487
Price
$574.84
Total Value
$279.95K
Shares Held After
27,556
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
153
Price
$573.82
Total Value
$87.79K
Shares Held After
28,043
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$572.40
Total Value
$274.75K
Shares Held After
28,196
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$571.00
Total Value
$22.84K
Shares Held After
28,676
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$570.06
Total Value
$45.60K
Shares Held After
28,716
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$568.60
Total Value
$45.49K
Shares Held After
28,796
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$582.29
Total Value
$139.75K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$581.78
Total Value
$233.29K
Shares Held After
40,753
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$580.98
Total Value
$325.35K
Shares Held After
41,154
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,104
Price
$579.27
Total Value
$639.52K
Shares Held After
41,714
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$578.58
Total Value
$92.57K
Shares Held After
42,818
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,039
Price
$577.26
Total Value
$599.77K
Shares Held After
42,978
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,677
Price
$576.39
Total Value
$2.12M
Shares Held After
44,017
% of Holdings
7.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$575.45
Total Value
$759.60K
Shares Held After
47,694
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
359
Price
$574.37
Total Value
$206.20K
Shares Held After
49,014
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$572.42
Total Value
$251.86K
Shares Held After
49,373
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$570.99
Total Value
$22.84K
Shares Held After
49,813
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$569.64
Total Value
$68.36K
Shares Held After
49,853
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$568.36
Total Value
$22.73K
Shares Held After
49,973
% of Holdings
0.1%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
5,230
Price
$31.29
Total Value
$163.66K
Shares Held After
4,367
% of Holdings
54.5%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$33.20
Total Value
$67.53K
Shares Held After
231,558
% of Holdings
0.9%
Edwards Lifesciences Corp (EW)
Lippis Daniel J. — CVP, TAVR
Shares
1,019
Price
$83.98
Total Value
$85.58K
Shares Held After
33,682
% of Holdings
2.9%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
15,000
Price
$15.33
Total Value
$229.95K
Shares Held After
198,588
% of Holdings
7.0%
Entrada Therapeutics, Inc. (TRDA)
Sethuraman Natarajan — President, Research & Develop.
Shares
25,907
Price
$15.39
Total Value
$398.81K
Shares Held After
216,317
% of Holdings
10.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$16.96
Total Value
$138.21K
Shares Held After
18,305
% of Holdings
30.8%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
100
Price
$71.34
Total Value
$7.13K
Shares Held After
1,032,504
% of Holdings
0.0%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
7,651
Price
$70.47
Total Value
$539.17K
Shares Held After
1,032,604
% of Holdings
0.7%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
47,963
Price
$0.72
Total Value
$34.53K
Shares Held After
1,679,330
% of Holdings
2.8%
Option Care Health, Inc. (OPCH)
Sethna Meenal — Chief Financial Officer
Shares
16,225
Price
$20.16
Total Value
$327.07K
Shares Held After
98,337
% of Holdings
16.5%
Option Care Health, Inc. (OPCH)
RADEMACHER JOHN CHARLES — Director
Shares
12,500
Price
$21.18
Total Value
$264.71K
Shares Held After
695,152
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
116
Price
$234.09
Total Value
$27.15K
Shares Held After
41,786
% of Holdings
0.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
105
Price
$232.57
Total Value
$24.42K
Shares Held After
41,902
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
165
Price
$231.87
Total Value
$38.26K
Shares Held After
42,007
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1
Price
$229.87
Total Value
$229.87
Shares Held After
42,172
% of Holdings
0.0%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
80
Price
$227.37
Total Value
$18.19K
Shares Held After
42,173
% of Holdings
0.2%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
902
Price
$206.16
Total Value
$185.96K
Shares Held After
149,867
% of Holdings
0.6%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
291
Price
$206.16
Total Value
$59.99K
Shares Held After
187,220
% of Holdings
0.2%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
330
Price
$206.16
Total Value
$68.03K
Shares Held After
222,694
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
150
Price
$206.93
Total Value
$31.04K
Shares Held After
142,295
% of Holdings
0.1%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
400
Price
$205.31
Total Value
$82.12K
Shares Held After
142,445
% of Holdings
0.3%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
865
Price
$204.47
Total Value
$176.86K
Shares Held After
142,845
% of Holdings
0.6%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
505
Price
$203.32
Total Value
$102.67K
Shares Held After
143,710
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
520
Price
$201.60
Total Value
$104.83K
Shares Held After
144,215
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
560
Price
$200.95
Total Value
$112.53K
Shares Held After
144,735
% of Holdings
0.4%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
405
Price
$206.16
Total Value
$83.49K
Shares Held After
145,295
% of Holdings
0.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
107
Price
$206.16
Total Value
$22.06K
Shares Held After
255,652
% of Holdings
0.0%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
313
Price
$206.16
Total Value
$64.53K
Shares Held After
57,978
% of Holdings
0.5%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
7,179
Price
$25.03
Total Value
$179.69K
Shares Held After
214,847
% of Holdings
3.2%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
7,144
Price
$22.99
Total Value
$164.22K
Shares Held After
32,600
% of Holdings
18.0%
Showing 3001–3050 of 5315 transactions (page 61 of 107)